BiondVax Pharmaceuticals Ltd (BVXV)

[TechKim]

I figure the company seems to have an estimated 12 months of cash to fuel this adventure. This is a guess. Then there are grants and such that might also be added to the fuel. I think it will be close going into the finish line. Then there comes the marketing fuel after the fact, but I would expect a big pharma to join in by then. That actually could even happen once the initial results of the phase 3 are known in 2017 (US-based Cytovance is beginning to scale-up production of BiondVax's universal flu vaccine candidate M-001 for Phase 3 clinical trials, which is expected to be ready by H1 2017.).


OPINION